Senior Biostatistician
Lindus HealthFull Time
Senior (5 to 8 years), Mid-level (3 to 4 years)
Candidates must possess a Master's or PhD in Biostatistics, Statistics, or a related field, with a minimum of 5 years of experience in a regulated healthcare environment, preferably in medical devices or diagnostics. Demonstrated experience supporting regulatory submissions with statistical content is required, along with proficiency in statistical software such as SAS, R, or STATA. A strong understanding of FDA, ICH, and ISO statistical requirements is essential, and experience with quality systems data, post-market surveillance analytics, and quality improvement methodologies is highly desirable. Excellent communication skills are also necessary to explain complex statistical concepts to non-statistical stakeholders.
The Biostatistician will provide statistical expertise for regulatory submissions, including PMAs, 510(k)s, IDEs, and responses to regulatory agency queries. They will support Quality Assurance and Quality Improvement teams by analyzing manufacturing, post-market surveillance, and complaint data to identify trends, monitor performance, and drive corrective and preventive actions. Responsibilities include designing and implementing statistical methods for quality monitoring, collaborating with cross-functional teams to design statistically sound protocols for clinical trials and real-world evidence studies, and developing and reviewing statistical analysis plans, protocols, and reports. The role ensures statistical methods and documentation meet FDA, EMA, and other global regulatory requirements, involves performing statistical analyses using SAS, R, or equivalent software, and contributing to internal audits and inspections by providing statistical justifications and documentation. Staying current with evolving regulatory guidelines and statistical best practices is also a key responsibility.
Advanced cardiac monitoring solutions provider
iRhythm Technologies focuses on cardiac monitoring solutions, with its main product being the Zio Patch, a wearable device that tracks heart rhythms for up to 14 days. This extended monitoring helps healthcare providers detect irregular heart rhythms that shorter monitoring might miss, making it especially useful for patients at risk. The company serves both patients and healthcare providers, generating revenue by selling the Zio Patch and offering data analysis services to interpret the collected heart data. iRhythm aims to improve patient outcomes and streamline healthcare workflows in the cardiac health sector.